glp 1 and tachycardia Differential effects of glucagon-like peptide-1 receptor agonists on heart rate | Cardiovascular Diabetology GLP-1 Receptor Agonists in Heart
Description
Records were reviewed for patient characteristics and medication type and doses
In real-world settings multiple factors contribute to non-persistence, including adverse effects, high cost-sharing and weight loss not meeting patients' expectations.
sales of GLP-1 drugs were $13.7 billion.
Struggling with semaglutide tiredness
Stricter FDA rules are reshaping GLP-1 access, opinions on regulation, and growing interest in alternatives like liraglutide.
